Filing metadata

Accession number
0001492422-25-000012
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Nov 18, 2025
Reporting period
Nov 17, 2025
Description
Insider transaction

Explore SEC Filings Hub